Aytu BioPharma (NASDAQ: AYTU) is a pharmaceutical company focused on developing and commercializing prescription therapeutics that address unmet patient needs. The company’s portfolio includes products across multiple therapeutic areas and is supported by commercialization and development capabilities designed to drive long-term growth.

Topics discussed include the company’s commercial portfolio, business strategy, growth initiatives, market opportunities, and long-term outlook.

This company webcast was recorded during the Lytham Partners Spring 2026 Investor Conference.